FSSAI’s ‘Food’ Fortification Move Unscientific: NGOs

Kochi : Agriculture welfare organizations have asked Food Safety and Standards Authority of India (FSSAI) to reconsider the proposal to make mandatory fortification of edible oil with Vitamin A and Vitamin D and rice with Vitamin B12, iron and folic acid.

“While we agree with FSSAI’s diagnosis that India faces a huge nutritional challenge, we strongly disagree with its prescription. We strongly urge FSSAI not to pursue this route and at the same time promote and highlight alternatives as well,” said Usha Soolapani, director of Thanal and co-convenor, Alliance for Sustainable and Holistic Agriculture (ASHA).

ASHA, which is an informal alliance of more than 400 organizations from across India working among other themes on sustainable agriculture and safe, diverse, sufficient and nutritious food, has flagged the move as ‘scientifically unproven’. Industry groups like Global Alliance for Improved Nutrition (GAIN) with which FSSAI’s food fortification resource centre works should not be involved in such assessment at all. GAIN has companies like BASF, Royal DSM amongst others, which carry a serious conflict of interest, in that they benefit from the huge market to be gained from fortification and their involvement is highly objectionable.

There are concerns around overdose, which is a major issue with mandatory fortification in that it does not discriminate for dosage within a given  population.

A study last year by Anura Kurpad, head of physiology at St John’s Medical Institute, Bengaluru, had cautioned that food fortification and iron tablet supplementation may expose women to excess iron, ASHA said in a statement.

There’s a need to promote awareness, working with other bodies and non-government organizations who are working on low cost, sustainable solutions, such as kitchen gardens, bran in diet and nutrition-rich diverse varieties of crops, suggests ASHA.

Related Posts

‘Smart’ Cancer Drug RK-251 Developed by Indian Scientists Could Offer Targeted Alternative to Chemotherapy

New Delhi:  Indian researchers have developed an experimental “smart” cancer drug designed to remain largely inactive in healthy tissues and activate primarily inside cancer cells, potentially reducing the severe side…

Andelyn Biosciences partners with Queen’s University to develop and manufacture gene therapy AAV9-GM2 to treat GM2 gangliosidoses

Andelyn bio sciences Inc, a leading patient-focused cell and gene therapy Contract Development and Manufacturing Organization (CDMO), has partnered with Queen’s University to develop and manufacture AAV9-GM2, a gene therapy…

Leave a Reply

Your email address will not be published. Required fields are marked *

You Missed

‘Smart’ Cancer Drug RK-251 Developed by Indian Scientists Could Offer Targeted Alternative to Chemotherapy

‘Smart’ Cancer Drug RK-251 Developed by Indian Scientists Could Offer Targeted Alternative to Chemotherapy

Andelyn Biosciences partners with Queen’s University to develop and manufacture gene therapy AAV9-GM2 to treat GM2 gangliosidoses

Andelyn Biosciences partners with Queen’s University to develop and manufacture gene therapy AAV9-GM2 to treat GM2 gangliosidoses

Cellution Biologics completes acquisition of SimpliDerm business for US$ 8 million from Elutia

Cellution Biologics completes acquisition of SimpliDerm business for US$ 8 million from Elutia

ACB Gujarat arrested two FDA Officials red-handed in Bharuch accepting a bribe of ₹40,000

ACB Gujarat arrested two FDA Officials red-handed in Bharuch accepting a bribe of ₹40,000

US appeals court sides with Sun Pharma in Lipitor antitrust case

US appeals court sides with Sun Pharma in Lipitor antitrust case

Counterfeit Cosmetics Are No Longer a Fringe Problem: 4 in 10 Consumers Report Fake Products, Regulatory Silence Raises Serious Questions

Counterfeit Cosmetics Are No Longer a Fringe Problem: 4 in 10 Consumers Report Fake Products, Regulatory Silence Raises Serious Questions